Home › Funds › Exome Asset Management LLC › CLYM
Exome Asset Management LLC position in CLYM
CLIMB BIO INC · Health Care
Exome Asset Management LLC reported holding 71,215 shares of CLYM (CLIMB BIO INC) in its Q3 2026 13F filing — a position valued at US$817K, representing 0.53% of its reported portfolio and ranking #47 among its reported holdings. Exome Asset Management LLC first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Exome Asset Management LLC's CLYM position evolved
Exome Asset Management LLC first disclosed a stake in CLYM in Q3 2026 at 71,215 shares (US$817K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 71.22K | $816.84K | New |
About CLYM and 13F data
CLYM (CLIMB BIO INC) is a Health Care company. 70 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLYM
- RA CAPITAL MANAGEMENT, L.P. 11.30M sh · $147.36M · Q2 2026
- BRAIDWELL LP 2.80M sh · $36.48M · Q2 2026
- Cormorant Asset Management, LP 2.11M sh · $27.46M · Q2 2026
- Redmile Group, LLC 1.23M sh · $15.99M · Q2 2026
- GREAT POINT PARTNERS LLC 1.00M sh · $13.04M · Q2 2026
- Affinity Asset Advisors, LLC 972.00K sh · $11.15M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 918.23K sh · $10.53M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 483.75K sh · $6.31M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 360.65K sh · $4.14M · Q3 2026
- Ally Bridge Group (NY) LLC 249.17K sh · $3.25M · Q2 2026
- ArchPoint Investors 132.90K sh · $1.52M · Q3 2026
More on Exome Asset Management LLC
FAQ
How long has Exome Asset Management LLC held CLYM?
Exome Asset Management LLC has disclosed CLYM holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Exome Asset Management LLC's current position in CLYM?
As of Q3 2026, Exome Asset Management LLC holds 71.22K shares of CLYM (CLIMB BIO INC), valued at $816.84K, representing 0.53% of its reported portfolio and ranking #47.
Has Exome Asset Management LLC been buying or selling CLYM?
In the latest 13F filing (Q3 2026), Exome Asset Management LLC newly opened its position in CLYM.
Which other funds hold CLYM?
Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.